GIF inhibits Th effector generation by acting on antigen-presenting B cells

被引:4
作者
Sugie, K
Huang, JY
机构
[1] La Jolla Inst Allergy & Immunol, Div Allergy, San Diego, CA 92121 USA
[2] La Jolla Inst Allergy & Immunol, Div Immunochem, San Diego, CA 92121 USA
关键词
D O I
10.4049/jimmunol.166.7.4473
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Glycosylation-inhibiting factor (GIF) is a 13-kDa cytokine secreted from T cells. Administration of bioactive recombinant GIF inhibits IgG1 and IgE Ab responses in vivo. Treatment of B cells with the cytokine reduces the secretion of IgG1 and IgE induced by LPS and IL-4. To examine the effect on cognate T-B interaction, GIF was added to low-density B cells from MD4 transgenic (Tg) mice, which express B cell receptor specific for hen egg lysozyme (HEL). The B cells were subsequently pulsed with HEL-OVA conjugate and cultured with OVA-specific naive CD4 T cells from DO11.10 Tg mice. Treatment of Ag-presenting B cells with GIF reduced expansion and IL-2 secretion of naive T cells and rendered them hyporesponsive to antigenic restimulation, resulting in 50-95% reduction of IL-4 and IFN-gamma secretion upon restimulation with Ag. GIF dramatically inhibited Th effector generation when it was added to B cells before pulsing with HEL-OVA, whereas it showed little to no effect when added after B cells were pulsed with Ag. GIF was more effective when B cells from MD4 Tg mice were pulsed with HEL-OVA than when they were pulsed with OVA. This cytokine did not affect Th effector generation when B cells or irradiated splenocytes pulsed with OVA(323-339) peptide stimulated naive DO11.10 T cells. Confocal microscopy revealed that GIF inhibited internalization of HEL by B cells from MD4 Tg mice. Therefore, the cytokine may regulate early steps of Ag presentation involving B cell receptors to diminish Th effector generation from naive CD4 T cells.
引用
收藏
页码:4473 / 4480
页数:8
相关论文
共 34 条
[31]   High-affinity binding of bioactive glycosylation-inhibiting factor to antigen-primed T cells and natural killer cells [J].
Sugie, K ;
Nakano, T ;
Tomura, T ;
Takakura, K ;
Mikayama, T ;
Ishizaka, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (10) :5278-5283
[32]  
Tomura T, 1999, J IMMUNOL, V162, P195
[33]   Posttranslational modification of the glycosylation inhibiting factor (GIF) gene product generates bioactive GIF [J].
Watarai, H ;
Nozawa, R ;
Tokunaga, A ;
Yuyama, N ;
Tomas, M ;
Hinohara, A ;
Ishizaka, K ;
Ishii, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (24) :13251-13256
[34]   T cell co-stimulatory molecules other than CD28 [J].
Watts, TH ;
DeBenedette, MA .
CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (03) :286-293